Why is Aarti Drugs falling/rising?

As of 24-Sep, Aarti Drugs Ltd's stock price is currently at 516.05, reflecting an increase of 2.6 (0.51%). The stock has shown a positive trend today, gaining after two consecutive days of decline, and opened with a gain of 2.99%. It reached an intraday high of Rs 528.8. Despite this upward movement, the stock has experienced a decrease in delivery volume, which fell by 24.94% compared to the 5-day average. Over the past month, the stock has outperformed the sector with a return of 6.67%, while its year-to-date performance stands at 12.03%. The company benefits from high management efficiency, a low debt-to-equity ratio, and attractive valuations, which may contribute positively to investor sentiment.
Broader market context indicates that while Aarti Drugs has performed well in the short term, the broader Sensex has declined by 1.18% over the past week. This contrast highlights the stock's resilience in a challenging market environment. Additionally, the stock's performance over the past year shows a slight decline of 2.63%, yet profits have increased by 20.4%, suggesting that the stock may be undervalued relative to its earnings growth. Overall, the combination of positive company fundamentals and recent price movements suggests a favorable outlook for Aarti Drugs amidst broader market challenges.